Alessia Pagana

Via S Sofia 78
Catania, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Is active surveillance of CIN2 always appropriate? Clinical outcomes and factors associated with progression and regression over 48 months in an HPV-positive cohort.

Is active surveillance of CIN2 always appropriate? Clinical outcomes and factors associated with progression and regression over 48 months in an HPV-positive cohort.

Journal: BMC cancer

Published: March 26, 2026

Persistent Low-Grade Squamous Intraepithelial Lesions and the Risk of Overtreatment: Evidence from Long-Term Active Surveillance.

Persistent Low-Grade Squamous Intraepithelial Lesions and the Risk of Overtreatment: Evidence from Long-Term Active Surveillance.

Journal: Cancers

Published: February 05, 2026

CIN2 and Active Surveillance: Evidence from 48-Month Follow-Up in an HPV-Positive Cohort.

CIN2 and Active Surveillance: Evidence from 48-Month Follow-Up in an HPV-Positive Cohort.

Journal: Cancers

Published: October 26, 2025

Locally Advanced Cervical Cancer: Multiparametric MRI in Gynecologic Oncology and Precision Medicine.

Locally Advanced Cervical Cancer: Multiparametric MRI in Gynecologic Oncology and Precision Medicine.

Journal: Diagnostics (Basel, Switzerland)

Published: September 19, 2025

CIN2 in the Era of Risk-Based Management and HPV Vaccination: Epidemiology, Natural History and Guidelines.

CIN2 in the Era of Risk-Based Management and HPV Vaccination: Epidemiology, Natural History and Guidelines.

Journal: Diagnostics (Basel, Switzerland)

Published: September 02, 2025

Imaging Biomarkers for HER2-Positive Breast Cancer: Evidence from an Observational Study.

Imaging Biomarkers for HER2-Positive Breast Cancer: Evidence from an Observational Study.

Journal: Journal of clinical medicine

Published: June 01, 2025

Endocervical Curettage and Extended HPV Genotyping as Predictors of Residual Disease After Hysterectomy in Postmenopausal Women Previously Treated with LEEP for CIN3: A Multivariate Analysis.

Endocervical Curettage and Extended HPV Genotyping as Predictors of Residual Disease After Hysterectomy in Postmenopausal Women Previously Treated with LEEP for CIN3: A Multivariate Analysis.

Journal: Cancers

Published: May 14, 2025

Role of endocervical curettage in detecting CIN2 + in postmenopausal women with persistent high-risk HPV and type 3 transformation zone.

Role of endocervical curettage in detecting CIN2 + in postmenopausal women with persistent high-risk HPV and type 3 transformation zone.

Journal: BMC cancer

Published: May 02, 2025

Magnetic Resonance Imaging in the Management of Women with Low-Risk Early-Stage Cervical Cancer: A Narrative Review.

Magnetic Resonance Imaging in the Management of Women with Low-Risk Early-Stage Cervical Cancer: A Narrative Review.

Journal: Diagnostics (Basel, Switzerland)

Published: February 08, 2025

Showing 1-9 of 9

Last Updated: 09/26/2026